ArticlePloS one2025

The SURVIVE study (NCT05658172): Bringing breast cancer aftercare to the 21stcentury: Study protocol of a Phase III clinical trial comparing liquid biopsy guided vs. Standard of care surveillance for intermediate to high-risk breast cancer survivors.

Tatjana Braun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.